Posts tagged as: ATGN stock quote back to homepage

AltiGen Records Lower Revenue in Q4, Trims Losses for Full Year(0)

AltiGen Communications, Inc. (OTCQX: ATGN) reported steeper losses Wednesday from the fourth quarter and fiscal years ended September 30, 2012, as the company booked a one-time, non-cash charge for excess inventory. Read More

Apple and Hammacher Store Sales Should Boost AltiGen’s iFusion Revenue Apple and Hammacher Store Sales Should Boost AltiGen’s iFusion Revenue(0)

Sales of AltiGen Communications’ (OTCQX:ATGN) could be getting a shot in the arm for the remainder of this quarter and in upcoming quarters as their revolutionary iFusion SmartStation is now available at the Apple, Inc.’s (NASDAQ:AAPL) Apple Store ( and the uber-popular Hammacher Schlemmer website ( Read More

AltiGen Shares up 83 Percent in January on Earnings and News AltiGen Shares up 83 Percent in January on Earnings and News(0)

Shares of Altigen Communications, Inc. (OTCQX: ATGN) continued on their upward trajectory again today, tacking-on another 17.02% to close at 55 cents on a noticeable increase in volume to nearly 200,000 shares changing hands today.  Shares of ATGN have appreciated by a whopping 83.33% so far in January since wrapping 2011 at 30 cents each. Read More

AltiGen Communications Stock Chart Analysis Video(0)

The AltiGen Communications (OTCQX: ATGN) chart looks to have found a bottom at 20 cents in December and is putting together a solid uptrend as the indicators are shifting from bearish to bullish. Some resistance is set at 35 cents, but solid support is nearby as the moving averages are curling underneath the price per share giving the chart a very solid appeal. Officially a Read More

AltiGen Partners with Eurodata Systems for U.K. Business(0)

San Jose, California-based AltiGen Communications, Inc. (OTCQX:ATGN) said today that it has partnered with award-winning, industry leader Eurodata Systems Ltd, an Information Technology services provider to the United Kingdom’s public and private sector to deliver AltiGen’s MaxACD contact center Read More

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.